Safety, Tolerability and Efficacy of Etelcalcetide in Hemodialysis Patients With Secondary Hyperparathyroidism
Clinical trial NCT01254565 · COMPLETED
Trial details
- NCT number
- NCT01254565
- Sponsor
- KAI Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-02-20
- Primary completion
- 2011-07-01
- Enrollment
- 87
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.